ArticleFrontiers in medicine2022

Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score.

Guangyu Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.